Anonymous ID: f57119 March 24, 2026, 6:01 a.m. No.24421009   🗄️.is 🔗kun   >>1062

Hmm…accident?

 

Oil Jumps After Explosion and Massive Fire at One of the Largest U.S. Oil Refineries

Right on cue.

Mar 24, 2026

 

A fire broke out at a diesel hydrotreater, with the unit suffering severe damage, according to people familiar with the incident. The fire was near the plant’s fluid catalytic cracker, and part of the refinery has been shut down, according to the people, who said a decision hasn’t yet been made whether to shut the entire plant.

 

The refinery can process 435,000 barrels of heavy sour crude a day, making it one of the top 10 largest refineries in the US.

 

News of the fire, coupled with fresh reports of hostilities in Iran, sent WTI crude - which earlier in the day dropped as low as $85 - back over $90 and rising.

 

https://www.vigilantfox.com/p/oil-jumps-after-explosion-and-massive

Anonymous ID: f57119 March 24, 2026, 6:18 a.m. No.24421084   🗄️.is 🔗kun   >>1400 >>1507 >>1748

What are the actual Influenza Vaccine risks? A data-driven look at flu vaccine adverse events

 

Federal safety databases document a range of side effects from annual influenza vaccination, from predictable and mild to rare and serious. Here is what the numbers show, what they mean for the policy debate over mandatory annual shots, and why the data sources themselves carry important caveats.

Whenever someone raises concerns about flu vaccine side effects, the response from official sources tends to follow a predictable script: the vaccine is safe and effective, serious side effects are extremely rare, and the benefits far outweigh the risks. All of that may be true in aggregate. But it tells you almost nothing useful about whether a specific person in a specific circumstance should receive a specific vaccine formulation.

 

A detailed analysis of federal safety surveillance data, drawn from the Vaccine Safety Datalink (VSD), the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS), and Medicare administrative claims covering tens of millions of vaccine recipients, offers a more granular picture. The data reveal a risk profile that is neither alarming nor trivial. It is genuinely heterogeneous, varying significantly by age, vaccine formulation, co-administration with other vaccines, and the specific adverse event.

 

For the ongoing policy debate over mandatory or near-mandatory annual influenza vaccination, this heterogeneity matters enormously. A risk-benefit calculation that makes clear sense for a frail 82-year-old in a nursing home may look quite different for a healthy 28-year-old office worker. Current policy treats both identically. The data suggest that risk-benefit considerations warrant closer examination.

 

https://www.malone.news/p/what-are-the-influenza-vaccine-risks